Literature DB >> 22174542

Genetic interactions and modifier genes in Hirschsprung's disease.

Adam S Wallace, Richard B Anderson.   

Abstract

Hirschsprung's disease is a congenital disorder that occurs in 1:5000 live births. It is characterised by an absence of enteric neurons along a variable region of the gastrointestinal tract. Hirschsprung's disease is classified as a multigenic disorder, because the same phenotype is associated with mutations in multiple distinct genes. Furthermore, the genetics of Hirschsprung's disease are highly complex and not strictly Mendelian. The phenotypic variability and incomplete penetrance observed in Hirschsprung's disease also suggests the involvement of modifier genes. Here, we summarise the current knowledge of the genetics underlying Hirschsprung's disease based on human and animal studies, focusing on the principal causative genes, their interactions, and the role of modifier genes.

Entities:  

Keywords:  Aganglionosis; Enteric nervous system; Hirschsprung’s disease; Modifier genes; Neural crest

Mesh:

Substances:

Year:  2011        PMID: 22174542      PMCID: PMC3236992          DOI: 10.3748/wjg.v17.i45.4937

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  96 in total

1.  Enteric nervous system development: analysis of the selective developmental potentialities of vagal and sacral neural crest cells using quail-chick chimeras.

Authors:  A J Burns; N M Le Douarin
Journal:  Anat Rec       Date:  2001-01-01

Review 2.  Mutations in Hirschsprung disease: when does a mutation contribute to the phenotype.

Authors:  R M Hofstra; J Osinga; C H Buys
Journal:  Eur J Hum Genet       Date:  1997 Jul-Aug       Impact factor: 4.246

3.  SOX10 mutations in patients with Waardenburg-Hirschsprung disease.

Authors:  V Pingault; N Bondurand; K Kuhlbrodt; D E Goerich; M O Préhu; A Puliti; B Herbarth; I Hermans-Borgmeyer; E Legius; G Matthijs; J Amiel; S Lyonnet; I Ceccherini; G Romeo; J C Smith; A P Read; M Wegner; M Goossens
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

4.  PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome.

Authors:  Delphine Trochet; Louise M O'Brien; David Gozal; Ha Trang; Agneta Nordenskjöld; Béatrice Laudier; Pär-Johan Svensson; Sabine Uhrig; Trevor Cole; Stephan Niemann; Arnold Munnich; Claude Gaultier; Stanislas Lyonnet; Jeanne Amiel
Journal:  Am J Hum Genet       Date:  2005-01-18       Impact factor: 11.025

5.  De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease.

Authors:  S M Ivanchuk; S M Myers; C Eng; L M Mulligan
Journal:  Hum Mol Genet       Date:  1996-12       Impact factor: 6.150

6.  Genetic interaction between Sox10 and Zfhx1b during enteric nervous system development.

Authors:  Laure Stanchina; Tom Van de Putte; Michel Goossens; Danny Huylebroeck; Nadege Bondurand
Journal:  Dev Biol       Date:  2010-03-04       Impact factor: 3.582

7.  Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer.

Authors:  Deborah Lang; Jonathan A Epstein
Journal:  Hum Mol Genet       Date:  2003-04-15       Impact factor: 6.150

8.  Localizing a putative mutation as the major contributor to the development of sporadic Hirschsprung disease to the RET genomic sequence between the promoter region and exon 2.

Authors:  Grzegorz M Burzynski; Ilja M Nolte; Jan Osinga; Isabella Ceccherini; Bas Twigt; Saskia Maas; Alice Brooks; Joke Verheij; Ivan Plaza Menacho; Charles H C M Buys; Robert M W Hofstra
Journal:  Eur J Hum Genet       Date:  2004-08       Impact factor: 4.246

9.  Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret.

Authors:  A Schuchardt; V D'Agati; L Larsson-Blomberg; F Costantini; V Pachnis
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

10.  Development of the enteric nervous system, smooth muscle and interstitial cells of Cajal in the human gastrointestinal tract.

Authors:  Adam S Wallace; Alan J Burns
Journal:  Cell Tissue Res       Date:  2005-01-26       Impact factor: 5.249

View more
  22 in total

Review 1.  Simple rules for a "simple" nervous system? Molecular and biomathematical approaches to enteric nervous system formation and malformation.

Authors:  Donald F Newgreen; Sylvie Dufour; Marthe J Howard; Kerry A Landman
Journal:  Dev Biol       Date:  2013-07-06       Impact factor: 3.582

2.  SRY interference of normal regulation of the RET gene suggests a potential role of the Y-chromosome gene in sexual dimorphism in Hirschsprung disease.

Authors:  Yunmin Li; Tatsuo Kido; Maria M Garcia-Barcelo; Paul K H Tam; Z Laura Tabatabai; Yun-Fai Chris Lau
Journal:  Hum Mol Genet       Date:  2014-09-28       Impact factor: 6.150

3.  RET gene is a major risk factor for Hirschsprung's disease: a meta-analysis.

Authors:  C Tomuschat; P Puri
Journal:  Pediatr Surg Int       Date:  2015-07-12       Impact factor: 1.827

Review 4.  Development and developmental disorders of the enteric nervous system.

Authors:  Florian Obermayr; Ryo Hotta; Hideki Enomoto; Heather M Young
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-12-11       Impact factor: 46.802

5.  Long non-coding RNA LOC100507600 functions as a competitive endogenous RNA to regulate BMI1 expression by sponging miR128-1-3p in Hirschsprung's disease.

Authors:  Yang Su; Zechao Wen; Qiyang Shen; Hua Zhang; Lei Peng; Guanglin Chen; Zhongxian Zhu; Chunxia Du; Hua Xie; Hongxing Li; Yankai Xia; Weibing Tang
Journal:  Cell Cycle       Date:  2018-02-12       Impact factor: 4.534

6.  A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk.

Authors:  David R Blair; Christopher S Lyttle; Jonathan M Mortensen; Charles F Bearden; Anders Boeck Jensen; Hossein Khiabanian; Rachel Melamed; Raul Rabadan; Elmer V Bernstam; Søren Brunak; Lars Juhl Jensen; Dan Nicolae; Nigam H Shah; Robert L Grossman; Nancy J Cox; Kevin P White; Andrey Rzhetsky
Journal:  Cell       Date:  2013-09-26       Impact factor: 41.582

7.  Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS.

Authors:  Hilary Schenck Eidam; John Russell; Kaushik Raha; Michael DeMartino; Donghui Qin; Huiping Amy Guan; Zhiliu Zhang; Gong Zhen; Haiyu Yu; Chengde Wu; Yan Pan; Gerard Joberty; Nico Zinn; Sylvie Laquerre; Sharon Robinson; Angela White; Amanda Giddings; Ehsan Mohammadi; Beverly Greenwood-Van Meerveld; Allen Oliff; Sanjay Kumar; Mui Cheung
Journal:  ACS Med Chem Lett       Date:  2018-05-24       Impact factor: 4.345

8.  MicroRNA-4516-mediated regulation of MAPK10 relies on 3' UTR cis-acting variants and contributes to the altered risk of Hirschsprung disease.

Authors:  Yang Wang; Qian Jiang; Aravinda Chakravarti; Hao Cai; Ze Xu; Wenjie Wu; Beilin Gu; Long Li; Wei Cai
Journal:  J Med Genet       Date:  2020-02-17       Impact factor: 6.318

Review 9.  The developmental etiology and pathogenesis of Hirschsprung disease.

Authors:  Naomi E Butler Tjaden; Paul A Trainor
Journal:  Transl Res       Date:  2013-03-22       Impact factor: 7.012

10.  Tcof1 acts as a modifier of Pax3 during enteric nervous system development and in the pathogenesis of colonic aganglionosis.

Authors:  Amanda J Barlow; Jill Dixon; Michael Dixon; Paul A Trainor
Journal:  Hum Mol Genet       Date:  2013-01-02       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.